Recent trends in chemotherapy of solid tumors.
A multidisciplinary approach consisting of surgery, radiotherapy, chemotherapy, and immunotherapy is now being used in both early and advanced stages of carcinoma. Positive and constructive approaches available today vary from adjuvant studies for early or primary disease to combinations of radiotherapy and chemotherapy for advanced disease. Methods of treatment considered to hold significant promise are discussed.
D000477:Alkylating Agents / Q000627:therapeutic use; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000188:drug therapy; D001943:Breast Neoplasms / Q000188:drug therapy; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy; D003520:Cyclophosphamide / Q000627:therapeutic use; D004938:Esophageal Neoplasms / Q000188:drug therapy / Q000532:radiotherapy; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage / Q000627:therapeutic use; D005770:Gastrointestinal Neoplasms / Q000188:drug therapy / Q000532:radiotherapy; D006258:Head and Neck Neoplasms / Q000188:drug therapy; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy; D008175:Lung Neoplasms / Q000188:drug therapy; D008545:Melanoma / Q000188:drug therapy; D008727:Methotrexate / Q000627:therapeutic use; D009369:Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy; D010190:Pancreatic Neoplasms / Q000188:drug therapy; D011882:Radiotherapy, High-Energy; D012509:Sarcoma / Q000188:drug therapy; D014565:Urogenital Neoplasms / Q000188:drug therapy
D000477:Alkylating Agents; D000903:Antibiotics, Antineoplastic; D000970:Antineoplastic Agents; D003520:Cyclophosphamide; D005472:Fluorouracil; D008727:Methotrexate